Medical and social aspects of preeclampsia
https://doi.org/10.30629/0023-2149-2024-102-1-12-18
Abstract
Preeclampsia (PE) is a relevant healthcare problem and represents a high risk for the development of various diseases in both the mother and fetus. In domestic and foreign literature, the number of works on the influence of PE on the cardiovascular and nervous systems of the fetus is constantly increasing. Thus, PE is associated with an increased risk of congenital heart defects, high blood pressure (BP), increased body mass index (BMI), and systemic vascular dysfunction in off spring. In addition, PE leads to disorders of the development of the nervous system, such as attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). PE is one of the main causes of adverse perinatal outcomes and neonatal mortality. This review also presents the correlation between PE and the risk of developing cardiovascular diseases (CVDs), stroke, and chronic kidney disease (CKD). In recent decades, there has been increasing evidence that manifestations of PE are not limited to pregnancy but also increase the risk of long-term complications. Thus, PE is a common disease that can lead to severe consequences for the mother and fetus in later life.
About the Authors
Yu. V. Shkurenko
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
Yulia V. Shkurenko — Assistant at the Department of Nursing; obstetrician-gynecologist
Moscow
A. D. Ibatov
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
Alexey D. Ibatov — Doctor of Medical Sciences, Head of the Department of Nursing, Institute of Psychology and Social Work
Moscow
U. E. Alieva
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
Ulkar Etibarkyzy Alieva — student
Moscow
References
1. Goffin S.M., Derraik J.G.B., Groom K.M., Cutfield W.S. Maternal pre-eclampsia and long-term offspring health: Is there a shadow cast? Pregnancy Hypertension. 2018:11–5. DOI: 10.1016/j.preghy.2018.02.003
2. Huang Ch., Li J., Qin G., Liew Z., Hu J., Krisztina D. et al. Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study. PLOS Medicine 2021;18(9). DOI: https://doi.org/10.1371/journal.pmed.1003805
3. Karatza A.A., Dimitriou G. Preeclampsia emerging as a novel risk factor for cardiovascular disease in the offspring. Current Pediatric Reviews. 2020;16(3):194–9. DOI: 10.2174/1573396316666191224092405
4. Sacks K.N., Friger M., Shoham-Vardi I., Spiegel E., Sergienko R., Landau D., Sheiner E. Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring. Pregnancy Hypertension. 2018;13:181–6. DOI: 10.1016/j.preghy.2018.06.013
5. Hung T.-H., Hsieh T.-T., Chen S.-F. Risk of abnormal fetal growth in women with early- and late-onset preeclampsia. Pregnancy Hypertension. 2018;12:201–6. DOI: 10.1016/j.preghy.2017.09.003
6. Kay V.R., Rätsep M.T., Figueiró-Filho E.A., Croy B.A. Preeclampsia may influence offspring neuroanatomy and cognitive function: a role for placental growth factor. Biology of Reproduction. 2019;101(2):271–83. DOI: 10.1093/biolre/ioz095
7. Rice M.M., Landon M.B., Varner M.W., Casey B.M., Reddy U.M., Wapner R.J. et al. Pregnancy-associated hypertension and offspring cardiometabolic health. Obstetrics and Gynecology. 2018;131(2):313–21. DOI: 10.1097/aog.0000000000002433
8. Miller F.C., Read J.A., Cabal L., Siassi B. Heart rate and blood pressure in infants of preeclamptic mothers during the first hour of life. Critical Care Medicine. 1983;11(7):532–5. DOI: 10.1097/00003246-198307000-00010
9. Andraweera P.H., Lassi Z.S. Cardiovascular risk factors in offspring of preeclamptic pregnancies—systematic review and meta-analysis. The Journal of Pediatrics. 2019;208:104–113. DOI: 10.1016/j.jpeds.2018.12.008
10. Yang F., Janszky I., Gissler M., Roos N., Wikström A., Yu Y. et al. Association of maternal preeclampsia with offspring risks of ischemic heart disease and stroke in nordic countries. JAMA Network Open. 2022;5(11). DOI: 10.1001/jamanetworkopen.2022.42064
11. Dyess N.F., Kinsella J.P. Cardiovascular implications for offspring born to mothers with preeclampsia. The Journal of Pediatrics. 2021;228:11–2. DOI: 10.1016/j.jpeds.2020.08.015
12. Lin I.C., Hsu T.Y., Tain Y.L., Tsai C.C., Huang H.C., Lai Y.J. et al. Coronary Dilatation and Endothelial Inflammation in Neonates Born to Mothers with Preeclampsia. The Journal of Pediatrics. 2021;228:58–65. DOI: 10.1016/j.jpeds.2020.07.059
13. Wang H., László K.D., Gissler M., Li F., Zhang J., Yu Y., Li J. Maternal hypertensive disorders and neurodevelopmental disorders in offspring: a population-based cohort in two Nordic countries. European Journal of Epidemiology. 2021;36(5):519–30. DOI: 10.1007/s10654-021-00756-2
14. Liu D., Gao Q., Wang Y., Xiong T. Placental dysfunction: The core mechanism for poor neurodevelopmental outcomes in the offspring of preeclampsia pregnancies. Placenta. 2022;126:224–32. DOI: 10.1016/j.placenta.2022.07.014
15. Sun B.Z., Moster D., Harmon Q.E., Wilcox A.J. Association of preeclampsia in term births with neurodevelopmental disorders in offspring. JAMA Psychiatry. 2020;77(8):823. DOI: 10.1001/jamapsychiatry.2020.0306
16. Maher G.M., O’Keeffe G.W., Kearney P.M., Kenny L.C., Dinan T.G., Mattsson M., Khashan A.S. Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offspring. JAMA Psychiatry. 2018;75(8):809. DOI: 10.1001/jamapsychiatry.2018.0854
17. Dachew B.A., Mamun A., Maravilla J.C., Alati R. Pre-eclampsia and the risk of autism-spectrum disorder in offspring: meta-analysis. The British Journal of Psychiatry. 2018;212(3):142–7. DOI: 10.1192/bjp.2017.27
18. Sverrisson F.A., Bateman B.T., Aspelund T., Skulason S., Zoega H. Preeclampsia and academic performance in children: A nationwide study from Iceland. Levine S.Z., editor. PLOS One. 2018;13(11). DOI: 10.1371/journal.pone.0207884
19. Leybovitz-Haleluya N., Wainstock T., Sheiner E. Maternal preeclampsia and the risk of pediatric gastrointestinal diseases of the offspring: A population-based cohort study. Pregnancy Hypertension. 2019;17:144–7. DOI: 10.1016/j.preghy.2019.06.005
20. Sacks K.N., Friger M., Shoham-Vardi I., Sergienko R., Landau D., Sheiner E. In utero exposure to pre-eclampsia as an independent risk factor for long-term respiratory disease. Pediatric Pulmonology. 2020;55(3):723–8. DOI: 10.1002/ppul.24659
21. Mirzakhani H., Carey V.J., McElrath T.F., Qiu W., Hollis B.W., O’Connor G.T. et al. Impact of preeclampsia on the relationship between maternal asthma and offspring asthma. An observation from the VDAART clinical trial. American Journal of Respiratory and Critical Care Medicine. 2019;199(1):32–42. DOI: 10.1164/rccm.201804-0770oc
22. Davidesko S., Nahum Sacks K., Friger M., Haim A., Sheiner E. Prenatal exposure to preeclampsia as a risk factor for long-term endocrine morbidity of the offspring. Hypertension in Pregnancy. 2020;40(1):21–8. DOI: 10.1080/10641955.2020.1854300
23. Kedar Sade E., Wainstock T., Tsumi E., Sheiner E. Prenatal exposure to preeclampsia and long-term ophthalmic morbidity of the offspring. Journal of Clinical Medicine. 2020;9(5):1271. DOI: 10.3390/jcm9051271
24. Pankiewicz K., Szczerba E., Maciejewski T., Fijalkowska A. Non-obstetric complications in preeclampsia. Menopausal Review. 2019;18(2):99–109. DOI: 10.5114/pm.2019.85785
25. Steinthorsdottir V. McGinnis R., Williams N.O., Stefansdottir L., Thorleifsson G., Shooter S. et al. Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women. 2020.11(1). DOI: 10.1038/s41467-020-19733-6
26. Selvaggi L., Loverro G., Schena F.P., Manno C., Cagnazzo G. Long term follow-up of women with hypertension in pregnancy. International Journal of Gynecology & Obstetrics. 1988;27(1):45–9. DOI: 10.1016/0020-7292(88)90086-0
27. Girsberger M., Muff C., Hösli I., Dickenmann M.J. Short term sequelae of preeclampsia: a single center cohort study. BMC Pregnancy and Childbirth. 2018;18(1):177. DOI: 10.1186/s12884-018-1796-z
28. Stuart J.J., Tanz L.J., Missmer S.A., Rimm E.B., Spiegelman D., James-Todd T.M., Rich-Edwards J.W. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development. Annals of Internal Medicine. 2018;169(4):224. DOI: 10.7326/m17-2740
29. Benschop L., Duvekot J.J., Versmissen J., van Broekhoven V., Steegers E.A.P., Roeters van Lennep J.E. Blood pressure profile 1 year after severe. Preeclampsia. Hypertension. 2018;71(3):491–8. DOI: 10.1161/hypertensionaha.117.10338
30. Cunningham M.W., LaMarca B. Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2018;315(3):R521–8. DOI: 10.1152/ajpregu.00218.2017
31. Brouwers L., Van der Meiden-van Roest A.J., Savelkoul C., Vogelvang T.E., Lely A.T., Franx A., van Rijn B.B. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2018;125(13):1642–54. DOI: 10.1111/1471-0528.15394
32. Lederer M., Wong A., Diego D., Nguyen D., Verma U., Chaturvedi S. Tracking the development of cerebrovascular risk factors following pregnancy with preeclampsia. Journal of Stroke and Cerebrovascular Diseases. 2020;29(6):104720. DOI: 10.1016/j.jstrokecerebrovasdis.2020.104720
33. McDermott M., Miller E.C., Rundek T., Hurn P.D., Bushnell C.D. Preeclampsia. Stroke. 2018;49(3):524–30. DOI: 10.1161/strokeaha.117.018416
34. Kittner S.J., Stern B.J., Feeser B.R., Hebel J.R., Nagey D.A., Buchholz D.W. et al. Pregnancy and the risk of stroke. New England Journal of Medicine. 1996;335(11):768–74. DOI: 10.1056/nejm199609123351102
35. Chuang C.J., Chiou W.Y., Yang H.J., Lin H.Y., Hung S.K., Lee M.S. et al. Impact of preeclampsia/eclampsia on hemorrhagic and ischemic stroke risk: A 17 years follow-up nationwide cohort study. PLOS ONE. 2022;17(11): 0276206. DOI: 10.1371/journal.pone.0276206
36. de Havenon A., Delic A., Stulberg E., Sheibani N., Stoddard G., Hanson H., Theilen L. Association of preeclampsia with incident stroke in later life among women in the Framingham Heart Study. JAMA Network Open. 2021;4(4):e215077. DOI: 10.1001/jamanetworkopen.2021.5077
37. Judy A.E., McCain Ch.L., Lawton E.S., Morton Ch.H., Main E.K., Druzin M.L. Systolic hypertension, preeclampsia-related mortality, and stroke in California. Obstetrics and Gynecology. 2019;133(6):1151–9. DOI: 10.1097/aog.0000000000003290
38. Paauw N.D., Van der Graaf A.M., Bozoglan R., Van der Ham D.P., Navis G., Gansevoort R.T. et al. Kidney function after a hypertensive disorder of pregnancy: a longitudinal study. American Journal of Kidney Diseases. 2018;71(5):619–26. DOI: 10.1053/j.ajkd.2017.10.014
39. Barrett P.M., McCarthy F.P., Evans M., Kublickas M., Perry I.J., Stenvinkel P., Khashan A.S., Kublickiene K. Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study. Myers JE. PLOS Medicine. 2020;17(8):e1003255. DOI: 10.1371/journal.pmed.1003255
40. Rangaswami J., Naranjo M., McCullough P.A. Preeclampsia as a form of type 5 cardiorenal syndrome: an underrecognized entity in women’s cardiovascular health. Cardiorenal Medicine. 2018;8(2):160–72. DOI: 10.1159/000487646
41. Bajpai D. Preeclampsia for the nephrologist: current understanding in diagnosis, management and long-term outcomes. Advances in Chronic Kidney Disease. 2020;27(6):540–50. DOI: 10.1053/j.ackd.2020.05.001
42. Kattah A. Preeclampsia and kidney disease: deciphering cause and effect. Current Hypertension Reports. 2020;22(11). DOI: 10.1007/s11906-020-01099-1
43. Yu L., Wang T., Que R., Yang J.,.Wang Zh, Jiang X., Wang L. The potentially protective role of ATP-binding cassette transporters in preeclampsia via Nrf2. Pregnancy Hypertension. 2019;18:21–8. DOI: 10.1016/j.preghy.2019.08.002
44. Lopes van Balen V.A., Spaan J.J., Cornelis T., Heidema W.M., Scholten R.R., Spaanderman M.E.A. Endothelial and kidney function in women with a history of preeclampsia and healthy parous controls: A case control study. Microvascular Research. 2018;116:71–6. DOI: 10.1016/j.mvr.2017.11.001
45. Li F., Wang T., Chen L., Zhang S., Chen L., Qin J. Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: A meta-analysis of cohort studies. Pregnancy Hypertension. 2021;24:107–17. DOI: 10.1016/j.preghy.2021.03.001
46. Khashan A.S., Evans M., Kublickas M., McCarthy F.P., Kenny L.C., Stenvinkel P. et al. Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. Taal MW. PLOS Medicine. 2019;16(7):e1002875. DOI: 10.1371/journal.pmed.1002875
47. Behboudi-Gandevani S., Amiri M., Rahmati M., Amanollahi Soudmand S., Azizi F., Ramezani Tehrani F. Preeclampsia and the ten-year risk of incident chronic kidney disease. Cardiorenal Medicine. 2020;10(3):188–97. DOI: 10.1159/000506469
48. Lopes van Balen V.A., Spaan J.J., Cornelis T., Spaanderman M.E.A. Prevalence of chronic kidney disease after preeclampsia. Journal of Nephrology. 2016;30(3):403–9. DOI: 10.1007/s40620-016-0342-1
49. Zhao G., Bhatia D., Jung F., Lipscombe L. Risk of type 2 diabetes mellitus in women with prior hypertensive disorders of pregnancy: a systematic review and meta-analysis. Diabetologia. 2021;64(3):491–503. DOI: 10.1007/s00125-020-05343-w
Review
For citations:
Shkurenko Yu.V., Ibatov A.D., Alieva U.E. Medical and social aspects of preeclampsia. Clinical Medicine (Russian Journal). 2024;102(1):12-18. (In Russ.) https://doi.org/10.30629/0023-2149-2024-102-1-12-18
Views:
439
Email this article 